These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3926664)

  • 1. The effect of progestins on the mitotic activity of uterine fibromyomas.
    Tiltman AJ
    Int J Gynecol Pathol; 1985; 4(2):89-96. PubMed ID: 3926664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    Wilson ES; Cruickshank J; McMaster M; Weir RJ
    Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A visual aid to the classification of oral contraceptives.
    Law B; Mumford JP; Hoonakker EW
    Curr Med Res Opin; 1974; 2(1):7-12. PubMed ID: 4135338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives, lipoproteins, and atherosclerosis.
    Adams MR; Clarkson TB; Shively CA; Parks JS; Kaplan JR
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 2):1388-93. PubMed ID: 2220963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relative expressed estrogenicity of the newer low-dose oral contraceptives.
    Rooks WH; Hanks M
    Fertil Steril; 1971 Apr; 22(4):251-4. PubMed ID: 5103030
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in plasma lipids caused by oral contraceptives].
    Kaffarnik H
    Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:67-72. PubMed ID: 4114609
    [No Abstract]   [Full Text] [Related]  

  • 11. [Progress in oral contraception. Advantages of a levonorgestrel-containing 3-stage preparation over low-dose levonorgestrel and desogestrel containing monophasic combination preparations].
    Lachnit-Fixson U
    Fortschr Med; 1984 Sep; 102(33):825-30. PubMed ID: 6383993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
    Lipson A; Stoy DB; LaRosa JC; Muesing RA; Cleary PA; Miller VT; Gilbert PR; Stadel B
    Contraception; 1986 Aug; 34(2):121-34. PubMed ID: 3096633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum copper and zinc in hormonal contraceptive users.
    Prema K; Ramalakshmi BA; Babu S
    Fertil Steril; 1980 Mar; 33(3):267-71. PubMed ID: 6444895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the site of action of oral contraceptive steroids. I. Effect of antifertility steroids on plasma LH levels and on the response to luteinizing hormone-releasing factor in rats.
    Schally AV; Carter WH; Saito M; Arimura A; Bowers CY
    J Clin Endocrinol Metab; 1968 Dec; 28(12):1747-55. PubMed ID: 4177382
    [No Abstract]   [Full Text] [Related]  

  • 15. Vasomotor symptoms and estrogen-progestogen therapy.
    von Schoultz B
    Acta Obstet Gynecol Scand Suppl; 1985; 132():15-8. PubMed ID: 3161264
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hormonal contraceptives on milk volume and infant growth. WHO Special Programme of Research, Development and Research Training in Human Reproduction Task force on oral contraceptives.
    Tankeyoon M; Dusitsin N; Chalapati S; Koetsawang S; Saibiang S; Sas M; Gellen JJ; Ayeni O; Gray R; Pinol A
    Contraception; 1984 Dec; 30(6):505-22. PubMed ID: 6241559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel.
    Gaspard UJ; Dubois M; Gillain D; Franchimont P; Duvivier J
    Contraception; 1984 Apr; 29(4):305-18. PubMed ID: 6430638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oral contraception on water-suppressed proton NMR spectra of plasma.
    Carlier PG; Vaesen F; Gilles RG; Fradin EA; Rorive GL
    Magn Reson Med; 1991 Jan; 17(1):269-73. PubMed ID: 1648654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen potency of oral contraceptive pills.
    Chihal HJ; Peppler RD; Dickey RP
    Am J Obstet Gynecol; 1975 Jan; 121(1):75-83. PubMed ID: 1115120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.